Clinical Trial Update: The Biosensor Using the Target Urine VOCs for Detecting DKD Diabetic Kidney Disease

View source ↗

Summary

A clinical trial investigating a urine VOC biosensor for detecting diabetic kidney disease and nephrotic syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Nephrotic Syndrome

Snippet

Sponsor: Suranaree University of Technology | Conditions: Urine VOCs From DKD and Nephrotic Syndrome Pateints | Status: WITHDRAWN